Roche's obesity candidate CT-388 shows promising weight loss results, with potential growth in their cardiometabolic pipeline ...

Roche RHHBY announced positive results from an early-stage study evaluating one of its recently acquired obesity drug ...

A new process developed at Cornell AgriTech can produce antioxidant-rich cold-pressed Concord grape juice with a longer shelf ...

This research comes from the GRADE study or Glycemia Reduction Approaches in Diabetes. It’s one of the longest and largest studies looking at certain combinations of medicines generally used to ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase Ib ...

which is characterized by imperfect management of glycemia, consequent chronic hyperglycemia, and relentless deterioration of ß-cell function. After type 2 diabetes patients initially respond to ...

The Cleveland Clinic notes that whole-wheat pasta is a good source of fiber and nutrients that can reduce disease risk. A ...

Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...

Protein is an essential molecule made up of amino acids. It plays a fundamental role in managing different bodily functions ...

Susp: administer by oral route only; do not give intravenously. Monitor for glycemia in diabetic patients. Chronic renal failure. Dialysis. Tabs: swallowing impairment (eg, recent or prolonged ...

Congratulations to the following faculty: The Glycemia Reduction Approaches in Diabetes study at UAB, conducted by Andrea Cherrington, M.D., (Interim Director, Prev Med) and colleagues report ...